Loading…
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
Ahmann, Andrew J., Capehorn, Matthew, Charpentier, Guillaume, Dotta, Francesco, Henkel, Elena, Lingvay, Ildiko, Holst, Anders G., Annett, Miriam P., Aroda, Vanita R.
Published in Diabetes care (01.02.2018)
Published in Diabetes care (01.02.2018)
Get full text
Journal Article
Loading…
Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
Blundell, John, Finlayson, Graham, Axelsen, Mads, Flint, Anne, Gibbons, Catherine, Kvist, Trine, Hjerpsted, Julie B.
Published in Diabetes, obesity & metabolism (01.09.2017)
Published in Diabetes, obesity & metabolism (01.09.2017)
Get full text
Journal Article
Loading…
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
Shaman, Ahmed M., Bain, Stephen C., Bakris, George L., Buse, John B., Idorn, Thomas, Mahaffey, Kenneth W., Mann, Johannes F.E., Nauck, Michael A., Rasmussen, Søren, Rossing, Peter, Wolthers, Benjamin, Zinman, Bernard, Perkovic, Vlado
Published in Circulation (New York, N.Y.) (22.02.2022)
Published in Circulation (New York, N.Y.) (22.02.2022)
Get full text
Journal Article
Loading…
Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes
Pirro, Valentina, Roth, Kenneth D, Lin, Yanzhu, Willency, Jill A, Milligan, Paul L, Wilson, Jonathan M, Ruotolo, Giacomo, Haupt, Axel, Newgard, Christopher B, Duffin, Kevin L
Published in The journal of clinical endocrinology and metabolism (01.02.2022)
Published in The journal of clinical endocrinology and metabolism (01.02.2022)
Get full text
Journal Article
Loading…
Loading…
Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment
Marbury, Thomas C., Flint, Anne, Jacobsen, Jacob B., Derving Karsbøl, Julie, Lasseter, Kenneth
Published in Clinical pharmacokinetics (01.11.2017)
Published in Clinical pharmacokinetics (01.11.2017)
Get full text
Journal Article
Loading…
Loading…
Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6
Klein, Klara R., Clemmensen, Kim K.B., Fong, Edwin, Olsen, Søren, Abrahamsen, Trine, Lingvay, Ildiko
Published in Diabetes care (01.02.2024)
Published in Diabetes care (01.02.2024)
Get full text
Journal Article
Loading…
Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist
Pontes-da-Silva, Rayane Miranda, de Souza Marinho, Thatiany, de Macedo Cardoso, Luiz Eduardo, Mandarim-de-Lacerda, Carlos Alberto, Aguila, Marcia Barbosa
Published in International Journal of Obesity (01.01.2022)
Published in International Journal of Obesity (01.01.2022)
Get full text
Journal Article
Loading…
What is the evidence regarding the safety of new obesity pharmacotherapies
Vidal, Josep, Flores, Lílliam, Jiménez, Amanda, Pané, Adriana, de Hollanda, Ana
Published in International Journal of Obesity (01.03.2025)
Published in International Journal of Obesity (01.03.2025)
Get full text
Journal Article
Loading…
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
Leiter, Lawrence A., Bain, Stephen C., Hramiak, Irene, Jódar, Esteban, Madsbad, Sten, Gondolf, Theis, Hansen, Thomas, Holst, Ingrid, Lingvay, Ildiko
Published in Cardiovascular diabetology (06.06.2019)
Published in Cardiovascular diabetology (06.06.2019)
Get full text
Journal Article
Loading…
A phase 1, randomized, double‐blind, placebo‐controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects
Xie, Panpan, Abildlund, Morten T., Bækdal, Tine A., He, Xuemei, Lyauk, Yassine K., Patted, Usha Rani H., Ning, Zu, Shi, Aixin
Published in Diabetes, obesity & metabolism (01.08.2024)
Published in Diabetes, obesity & metabolism (01.08.2024)
Get full text
Journal Article
Loading…
Efficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis
Ren, Xiaoyu, Hua, Honghao, Wu, Yuanqin, Zhang, Wei, Long, Xianzhen, Bai, Yana, Cheng, Ning
Published in Scientific reports (06.07.2025)
Published in Scientific reports (06.07.2025)
Get full text
Journal Article
Loading…
Semaglutide and heart failure: Updated meta-analysis
Barbagelata, Leandro, Masson, Walter, Lobo, Martín, Bluro, Ignacio
Published in Current problems in cardiology (01.09.2024)
Published in Current problems in cardiology (01.09.2024)
Get full text
Journal Article
Loading…
De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial (TRANSITION‐T2D)
Rodriguez, Paloma, Breslaw, Nikki, Xiao, Huijun, Bena, Jim, Jenkins, Kimberly, Isaacs, Diana, Zhou, Keren, Griebeler, Marcio L., Burguera, Bartolome, Pantalone, Kevin M.
Published in Diabetes, obesity & metabolism (01.02.2025)
Published in Diabetes, obesity & metabolism (01.02.2025)
Get full text
Journal Article
Loading…
Comparative cardiovascular and renal outcomes of Liraglutide versus Dulaglutide in Asian type 2 diabetes patients
Dai, Jhih-Wei, Lin, Yuan, Li, Xiu-Wei, Tseng, Chin-Ju, Tsai, Ming-Lung, Yang, Ning-I, Hung, Ming-Jui, Chen, Tien-Hsing
Published in Scientific reports (11.11.2024)
Published in Scientific reports (11.11.2024)
Get full text
Journal Article
Loading…
Oral semaglutide for the treatment of obesity: a retrospective real-world study
Krajnc, Mitja, Kuhar, Neža, Koceva, Andrijana
Published in Frontiers in endocrinology (Lausanne) (29.05.2025)
Published in Frontiers in endocrinology (Lausanne) (29.05.2025)
Get full text
Journal Article
Loading…
The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial
Golub, Ilana S., Manubolu, Venkat S., Aldana-Bitar, Jairo, Dahal, Suraj, Verghese, Dhiran, Alalawi, Luay, Krishnan, Srikanth, Kianoush, Sina, Benzing, Travis, Ichikawa, Keishi, Kinninger, April, Fazlalizadeh, Hooman, Pourafkari, Leili, Ahmad, Khadije, Susarla, Shriraj, Mangaoang, Czarina, Ghanem, Ahmed K., Javier, Denise Alison, Hamal, Sajad, Roy, Sion K., Budoff, Matthew J.
Published in Nutrition, metabolism, and cardiovascular diseases (01.09.2025)
Published in Nutrition, metabolism, and cardiovascular diseases (01.09.2025)
Get full text
Journal Article
Loading…
Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report
Dinoi, Elisa, Daniele, Giuseppe, Michelucci, Angela, Baldinotti, Fulvia, Campi, Fabrizio, Marchetti, Piero, Del Prato, Stefano, Dardano, Angela
Published in Frontiers in endocrinology (Lausanne) (10.02.2025)
Published in Frontiers in endocrinology (Lausanne) (10.02.2025)
Get full text
Journal Article